报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 85.5% | -3.75% | -2.75% | 10/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 87.91% | -0.13% | -2.01% | 9/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 89.72% | 4.47% | -0.57% | 8/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 90.23% | 3.49% | 1.58% | 7/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 88.83% | 1.16% | 0.91% | 9/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 88.02% | -0.18% | 2.5% | 12/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 85.88% | -3.71% | -1.51% | 15/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 87.19% | -1.24% | -0.7% | 12/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 87.81% | -0.79% | -0.42% | 14/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 88.18% | -0.09% | -1.12% | 14/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 89.18% | 1.01% | 1.01% | 14/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 88.29% | -0.03% | -0.24% | 14/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 88.5% | 2% | 0.28% | 14/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 88.26% | -0.68% | -0.04% | 13/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2021-03-31 | 88.3% | 2% | -0.02% | 12/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
2020-12-31 | 88.31% | -2.28% | -0.62% | 14/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
2020-06-30 | 88.87% | 2% | -1.67% | 12/54 | 88.2% | 义翘神州 | 96.56% | 行业排名> |
2019-12-31 | 90.38% | 1.61% | 1.61% | 9/54 | 72.44% | 华兰疫苗 | 707.43% | 行业排名> |
2018-12-31 | 88.95% | -0.01% | -0.01% | 9/54 | 71.54% | 我武生物 | 95.6% | 行业排名> |
2017-12-31 | 88.96% | 2% | 2% | 7/54 | -887.82% | 我武生物 | 96.43% | 行业排名> |